Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
AB Sciex
AB Sciex
Activities:
Manufacturing
Analysis
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Analysis
QTOF mass spectrometry for faster biotherapeutics characterisation
Sciex focuses on reproducible data and education for biologics labs with the X500B QTOF at World ADC Summit
Research & Development
SCIEX supports vital cancer prevention research through partnership with World Cancer Research Fund
SCIEX’s donation to the WCRF follows several significant research partnerships with world-leading cancer scientists to advance the promise of precision medicine
Research & Development
Scientists eradicate leukemic stem cells by targeting cell survival proteins
SCIEX mass spectrometry-based solutions lead to leukemia breakthroughs – advancing precision medicine
Analysis
SCIEX and CW Analytical collaborate to develop first cannabis testing standards
SCIEX workflow solution enables legalised cannabis labs to facilitate routine testing with robust, cost-effective analytical methods
Research & Development
SCIEX joins forces with the Francis Crick Institute and the University of Cambridge to establish understanding of metabolism
New proteomic study to develop advanced resource for precision medicine research by using Microflow SWATH acquisition
Analysis
University of Manchester and SCIEX open £18m Biomarker Discovery Centre
The Manchester, UK-based Stoller Biomarker Discovery Centre is a major step forward in precision medicine and making 'industrial' proteomics a reality
Research & Development
Sciex and A*STAR’s Bioprocessing Technology Institute sign multi-year deal
With the aim of advancing biologics research & development in Singapore
Subscribe now